Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 06, 2023

SELL
$3.38 - $4.22 $949 - $1,185
-281 Reduced 1.08%
25,766 $94,000
Q3 2022

Nov 02, 2022

BUY
$3.43 - $5.83 $88,583 - $150,565
25,826 Added 11685.97%
26,047 $93,000
Q2 2022

Aug 12, 2022

BUY
$4.41 - $5.69 $974 - $1,257
221 New
221 $1,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.